119 related articles for article (PubMed ID: 5139499)
1. The effects of cyclophosphamide and nor-nitrogen mustard administration to one-day-old mice.
Short R; Gibson J
Experientia; 1971 Jul; 27(7):805-6. PubMed ID: 5139499
[No Abstract] [Full Text] [Related]
2. [Possibilities of decreasing the toxicity of lethal doses of radiominetics by the use of radioprotectors].
Pantev T; Petkova S
Eksp Med Morfol; 1978; 17(1):14-8. PubMed ID: 639742
[No Abstract] [Full Text] [Related]
3. Carcinogenicity of alkylating agents.
Weisburger EK
Public Health Rep (1896); 1966 Sep; 81(9):772-6. PubMed ID: 4957936
[No Abstract] [Full Text] [Related]
4. [Effect of N-mustard on the development of accessory ribs in mouse fetus].
Heinecke H; Klaus S
Arzneimittelforschung; 1972 Jan; 22(1):122-5. PubMed ID: 5066984
[No Abstract] [Full Text] [Related]
5. [Experimental study of the antitumor activity and toxicity of the preparation, Peptichemio].
Balitskiĭ KP; Veksler IG; Tsapenko VF
Vopr Onkol; 1979; 25(7):105. PubMed ID: 483671
[No Abstract] [Full Text] [Related]
6. Comparison of current alkylating agents with a homo-aza-steroidal ester for antineoplastic activity.
Catsoulacos P; Papageorgiou A; Margarity E; Mourelatos D; Mioglou E
Oncology; 1994; 51(1):74-8. PubMed ID: 8265107
[TBL] [Abstract][Full Text] [Related]
7. [A volatile alkylating agent in the exhaled air following the administration of Endoxan].
Rauen HM; Norpoth K
Klin Wochenschr; 1968 Mar; 46(5):272-5. PubMed ID: 5697858
[No Abstract] [Full Text] [Related]
8. [Study of the toxic effect of antineoplastic agents].
Iushkov SF
Farmakol Toksikol; 1971; 34(1):83-91. PubMed ID: 5570716
[No Abstract] [Full Text] [Related]
9. Carcinogenicity of alkylating cytostatic drugs in animals.
Berger MR
IARC Sci Publ; 1986; (78):161-76. PubMed ID: 3583389
[No Abstract] [Full Text] [Related]
10. Trichlormethine (trimustine hydrochloride).
IARC Monogr Eval Carcinog Risks Hum; 1990; 50():143-9. PubMed ID: 2292796
[No Abstract] [Full Text] [Related]
11. Comparison of cytotoxicity of single dose and infusion of alkylating agents.
Valeriote F; Vietti T
Cancer Drug Deliv; 1985; 2(1):11-8. PubMed ID: 4052923
[TBL] [Abstract][Full Text] [Related]
12. Test for carcinogenicity of food additives and chemotherapeutic agents by the pulmonary tumor response in strain A mice.
Stoner GD; Shimkin MB; Kniazeff AJ; Weisburger JH; Weisburger EK; Gori GB
Cancer Res; 1973 Dec; 33(12):3069-85. PubMed ID: 4202501
[No Abstract] [Full Text] [Related]
13. Use of the asparagine auxotroph of the L5178Y murine leukemia for the detection of chemical mutagens in vitro and in the host-mediated assay.
Capizzi RL; Summers WP; Papirmeister B
Environ Health Perspect; 1973 Dec; 6():137-43. PubMed ID: 4360721
[No Abstract] [Full Text] [Related]
14. Modulation of the toxicity and antitumour activity of alkylating drugs by steroids.
Shepherd R; Harrap KR
Br J Cancer; 1982 Mar; 45(3):413-20. PubMed ID: 7073935
[TBL] [Abstract][Full Text] [Related]
15. 3-N,N-bis(2-chloroethylamino)p-toluic acid, a new cytostatic drug active in cancer.
Dobre V; Maltezeanu G
Cancer Chemother Rep; 1970 Oct; 54(5):319-23. PubMed ID: 5514620
[No Abstract] [Full Text] [Related]
16. Experimental investigations with anti-cancer drugs for carcinogenicity with special reference to immunedepression.
Schmähl D
Recent Results Cancer Res; 1975; (52):18-28. PubMed ID: 1234999
[No Abstract] [Full Text] [Related]
17. Dose-response curves for agents that impair cell reproductive integrity. A fundamental difference between dose-response curves of antimetabolites and those for radiation and alkylating agents.
Berenbaum MC
Br J Cancer; 1969 Jun; 23(2):426-33. PubMed ID: 5788051
[No Abstract] [Full Text] [Related]
18. Comparative antitumor effects of peptichemio and other alkylating agents.
Schmid FA; Banks SE; Stock CC
Cancer Treat Rep; 1977; 61(3):473-5. PubMed ID: 872145
[No Abstract] [Full Text] [Related]
19. Alkylating agents in bronchogenic carcinoma.
Green RA; Humphrey E; Close H; Patno ME
Am J Med; 1969 Apr; 46(4):516-25. PubMed ID: 5791000
[No Abstract] [Full Text] [Related]
20. Cellular pharmacokinetics of the phenylalanine mustards.
Vistica DT
Pharmacol Ther; 1983; 22(3):379-406. PubMed ID: 6361804
[No Abstract] [Full Text] [Related]
[Next] [New Search]
